Stein, Eytan
Xie, Jipan
Duchesneau, Emilie
Bhattacharyya, Subrata
Vudumula, Umakanth
Ndife, Briana
Bonifacio, Gaetano
Guerin, Annie
Li, Nanxin
Joseph, George
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
First Online: 1 November 2018
Compliance with Ethical Standards
:
: This study was funded by Novartis Pharmaceuticals Corporation.
: Eytan Stein has received consultancy fees and/or research funding from Novartis, Agios Pharmaceuticals, Celgene Corporation, Pfizer, GlaxoSmithKline, Seattle Genetics, and Constellation Pharma. Umakanth Vudumula is an employee of Novartis Healthcare Private Limited. Briana Ndife, Gaetano Bonifacio, and George Joseph are employees of Novartis Pharmaceuticals Corporation and own stock/stock options in the company. Jipan Xie and Annie Guerin are employees of Analysis Group, which has received consultancy fees from Novartis Pharmaceuticals Corporation for this study. Subrata Bhattacharya was an employee of Novartis Healthcare Pvt. Ltd at the time this study was conducted. Nanxin Li and Emilie Duchesneau were employees of Analysis Group at the time this study was conducted.
: This study did not involve human participants, therefore no formal consent was required.
: Model inputs are described within the article. The model was developed in Microsoft Excel and is not publicly available, but is available from the authors upon reasonable request, with authorization from Novartis Pharmaceuticals Corporation and receipt of a signed confidentiality agreement.